tradmap

CURX Earnings Curanex Pharmaceuticals Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$0 -$0 $0 2024 2025
EPS
Net income (annual)
-$4M -$2M $0 2024 2025
Net income
Return on equity (annual)
-72% -36% 0% 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$0 -$0 $0 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Net income (quarterly)
-$3M -$2M $0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
Net income
Return on equity (quarterly)
-69% -34% 0% Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26
ROE

Reported EPS history

1–9 of 9
Q2 20262026-06-30-0.232026-08-1410-Q
Q1 20262026-03-31-0.112026-05-1410-Q
FY 20252025-12-31-0.172026-03-3010-K
Q3 20252025-09-30-0.052025-11-1710-Q
Q2 20262025-06-30-0.012026-08-1410-Q
Q1 20262025-03-31-0.012026-05-1410-Q
FY 20252024-12-31-0.032026-03-3010-K
Q3 20252024-09-30-0.052025-11-1710-Q
Q2 20252024-06-30-0.052025-09-0910-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.